Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 21, 2026.

Virulence of newcastle disease virus: what is known so far?

Jos CFM Dortmans, Guus Koch, Peter JM Rottier and 1 more

Veterinary Research · 2011 · Review

doi:10.1186/1297-9716-42-122

Abstract

In the last decade many studies have been performed on the virulence of Newcastle disease virus (NDV). This is mainly due to the development of reverse genetics systems which made it possible to genetically modify NDV and to investigate the contribution of individual genes and genome regions to its virulence. However, the available information is scattered and a comprehensive overview of the factors and conditions determining NDV virulence is lacking. This review summarises, compares and discusses the available literature and shows that virulence of NDV is a complex trait determined by multiple genetic factors.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 21, 2026. Paragraph numbers are ours, so an answer can point at one.

Table of contents

1 Introduction

2 Determination of NDV virulence

3 Newcastle disease virus

4 Viral entry proteins: major virulence determinants

5 Immune evasion and virulence

6 Replication and virulence

7 Non-coding regions

8 Concluding remarks

9 Acknowledgements

10 Competing interests

11 Authors' contributions

12 References

1. Introduction

The virulence of a virus is determined by multiple genetic factors. These may involve its tissue or organ tropism, its ability to deal with the host's immune system and/or its efficacy of replication. In the literature the definition of a virulence factor or virulence determinant is not always clear-cut. Thus, many studies concluded that if a genetic mutation in a gene or a complete knock out of the gene function results in an attenuated phenotype, this particular gene or amino acid sequence is a virulence determinant. However, some proteins or protein domains are involved in basic replication processes, making them essential for virus reproduction. Hence, the terms "virulence factor" and "virulence determinant" should be used with care. Our definition of a virulence determinant is: a naturally occurring genetic difference between strains of the same species that is responsible for their difference in virulence. However, nowadays reverse genetics allows the genetic modification of viral genomes almost at will and as a consequence the effects of genetic modifications that have not been encountered in nature can also be studied. Indeed, these techniques have resulted in much more detailed information on the involvement of viral genes and proteins in the virus life cycle and consequently on their contribution to virulence. Therefore, it is arguable whether a particular "artificial" genetic difference still meets the above mentioned definition of a virulence determinant. Similar effects may occur in nature but may be countered by other factors or may be too subtle to be determined by the particular test used to measure differences in virulence.

Newcastle disease (ND) is one of the most important infectious diseases of poultry. It is distributed worldwide and has the potential to cause large economic losses in the poultry industry. Its causative agent is Newcastle disease virus (NDV), a virus that is able to infect over 240 species of birds and which spreads primarily through direct contact between infected and healthy birds. The first outbreaks of ND in Java, Indonesia, and Newcastle-upon-Tyne, England, were reported during the mid-1920s. Within a few years ND had spread throughout the world and became endemic in many countries.

NDV occurs in the field as a variety of strains which differ extensively in the organ systems that they affect and in the severity of the symptoms that they produce in infected birds. Based on the severity of the disease in chickens, NDV has been classified into three pathotypes: lentogenic, mesogenic and velogenic. Lentogenic NDV strains cause subclinical infection with mild respiratory or enteric disease and are considered low-virulent. Mesogenic NDV strains are of intermediate virulence causing respiratory infection with moderate mortality (< 10%), while velogenic NDV strains are highly virulent causing mortality rates up to 100%. Velogenic strains are further classified into viscerotropic velogenic and neurotropic velogenic strains. Viscerotropic velogenic strains produce lethal haemorrhagic lesions in the viscera, whereas neurotropic velogenic strains cause neurological and respiratory disorders. The study of virulence and the identification of viral determinants of disease severity is important because an understanding of the mechanisms underlying the outcome of infection may enable a more effective prophylactic or therapeutic approach for viral diseases.

2. Determination of NDV virulence

Low virulent NDV strains need the addition of exogenous trypsin to spread from cell to cell and to form syncytia in cell culture monolayers, whereas virulent strains do not. Therefore, it was already suggested that the NDV plaque size correlates with virulence. However, other studies have shown that the plaque size is highly dependent on the use of certain viral mutants, strains and cell types, and that it cannot be considered as a reliable marker for viral virulence, leaving the study of this crucial biological feature unfortunately to the realm of animal experimentation.

Useful in vivo tests for the assessment of virulence are the mean death time (MDT) in embryonated chicken eggs, the intravenous pathogenicity index (IVPI) in six-week-old chickens and the intracerebral pathogenicity index (ICPI) in one-day-old chickens. Although in most cases the MDT and the IVPI may give a useful indication of virulence, they are considered to be imprecise, particularly when used to assess viruses isolated from hosts other than chickens. Consequently, these assays are not considered sufficiently reliable for the characterization of NDV isolates in case of a suspected outbreak.

The generally accepted method to measure the virulence of NDV strains is the ICPI, because of its established accuracy and sensitivity. The variation in virulence of different NDV isolates is reflected in the index which ranges from 0.0 (avirulent viruses) to 2.0. (high virulent viruses). Although useful for the sake of defining virus virulence for control purposes, the use of the ICPI for virulence determination for research goals may be criticized, particularly because intracerebral inoculation is obviously an unnatural way of infection. Indeed, in some cases phenotypic differences observed after intracerebral infection were not observed when the natural infection route was used. It should also be noted, that some differences may exist in the execution of the test. In some studies non-standard amounts of inoculum were used for the ICPI. In these particular studies 103 plaque forming units (PFU) were used per chicken, which is probably much less than the amount of virus in the inoculum prescribed by the World Organisation for Animal Health (OIE) and EU guidelines that consists of a 1 to 10 dilution of allantoic fluid with an haemagglutination (HA) titre of at least 24. Nevertheless, despite these discrepancies the ICPI test in general is a reliable and reproducible test providing a good indication of the relative virulence of different viruses.

3. Newcastle disease virus

NDV is a paramyxovirus and viruses from this family are enveloped, non-segmented, negative-sense RNA viruses, which - together with the Pneumovirinae - constitute the family of Paramyxoviridae. NDV, or avian paramyxovirus type 1 (APMV-1), is classified in the genus Avulavirus of the subfamily Paramyxovirinae. NDV viruses belong to one serotype and there are two classes. The genome of class I viruses consists of 15 198 nucleotides (nt) and the genome of class II viruses consists of 15 186 or 15 192 nt.. The genome contains six open reading frames (ORF) which encode the nucleoprotein (NP), the phosphoprotein (P), the matrix protein (M), the fusion protein (F), the haemagglutinin-neuraminidase (HN) and the large protein (L). At least one additional, non-structural protein (V) and possibly a second one (W), are generated by RNA editing during P gene transcription.

Virus infection is initiated by attachment of the virion to the surface of the target cell. Binding of the viral HN glycoprotein to sialic acid-containing cell surface proteins, which serve as receptors, triggers the F protein-promoted fusion of the viral envelope with the plasma membrane of the host cell through a pH-independent mechanism, similar to other paramyxoviruses. The viral nucleocapsid or ribonucleoprotein complex (RNP) contains the RNA genome encapsidated with NP and associated with the polymerase complex composed of the P and L proteins. After entry, the viral nucleocapsid dissociates from the M protein and is released into the cytoplasm. Subsequently, the polymerase complex transcribes the viral genomic RNA to produce the mRNAs that are required for the synthesis of the viral proteins. Binding of the polymerase complex to the nucleocapsid is mediated by the P protein, whereas the catalytic activities are functions of the L protein.

The switch from transcription to genome replication takes place when sufficient amounts of viral protein have accumulated. The polymerase complex is responsible for the synthesis of full-length plus-strand antigenomic RNA, which in turn serves as the template for synthesis of minus-strand genomic RNA. Viral nucleocapsids are then assembled by association of NP with the newly formed genomic RNA and with the polymerase complex. All components of the virus particle are transported to the plasma membrane where they are assembled under the direction of the M protein. Virions are released from the cell by a process of budding (reviewed in). Finally, the neuraminidase activity of the HN protein facilitates the detachment of the virus from the cell and removes sialic acid residues from progeny virus particles to prevent self-aggregation.

The genome of negative-strand RNA viruses is exclusively present in viral particles in the form of the RNP; naked viral RNA is not infectious. However, the development of reverse genetics for negative-strand RNA viruses has allowed the production of infectious virus from cloned cDNAs and has made genetic modification possible (reviewed in and). Currently, reverse genetics systems for NDV are available for the lentogenic strains LaSota Hitchner B1 and AV324/96, the mesogenic strains Beaudette C and Anhinga and the velogenic strains Herts/33, ZJ1 and RecP05. It should be noted that most rescued viruses are less virulent than the parental wild-type virus from which they were derived. This observation might be explained by genomic bottlenecks during the cloning process that result in loss of genomic variability and viral population fitness. Nevertheless, the availability of a reverse genetics system for NDV as well as for other viruses has provided essential information and tools to study the molecular mechanism of viral replication and pathogenesis in great detail.

4. Viral entry proteins: major virulence determinants

Entry of many enveloped viruses, including NDV, into host cells often requires the activation of viral fusion glycoproteins through cleavage by intracellular or extracellular proteases. It has been shown that viral glycoprotein activation is often mediated by proteases recognizing either monobasic or multi-basic cleavage sites. In the early days, virulence studies were performed after exposing NDV strains to mutagens in order to induce differences in the functionality of certain proteins. As a result, the mutants gained or lost the ability to form plaques in cell culture and had a shorter or extended MDT in embryonated chicken eggs. Extensive in vitro studies of Nagai et al. showed that in all studied NDV strains, virulence in chickens correlated with cleavage of the F protein of the virus. Cleavage of the precursor glycoprotein F0 into F1 and F2 by host cell proteases is essential for progeny virus to become infective. Lentogenic viruses have a monobasic amino acid motif at the F cleavage site, 112G-R/K-Q-G-R↓L117, and are cleaved extracellularly by trypsin-like proteases found in the respiratory and intestinal tract. Mesogenic and velogenic strains have a multi-basic amino acid motif at the F cleavage site, 112R/G/K-R-Q/K-K/R-R↓F117 and can be cleaved intracellularly by ubiquitous furin-like proteases. This results in a systemic infection that is often fatal. Thus, viral replication in the animal is dependent on proteolytic activation of the virus, as predicted from the previous studies in cell culture and chick embryos. It could be concluded that the amino acid sequence at the F protein cleavage site is a major determinant of NDV virulence.

Consistently, studies with recombinant NDVs generated by means of reverse genetics showed that the virulence increased significantly when the cleavage site of a lentogenic strain was converted into that of a velogenic strain. In these studies the ICPI increased from 0.00-0.01 to 1.12-1.28 (Table 1). Furthermore, the ICPI of velogenic NDV strain ZJ1 could be decreased from 1.89 to 0.13 by changing 3 nucleotides in the genome sequence that specifies the cleavage site. Also a single amino acid change, Q114R, in the cleavage site resulted in a decrease in the ICPI index. However, there are observations indicating that the ICPI does not always correlate with the severity of clinical disease in adult chickens inoculated via a natural route of infection. In one study, for example, 4-week-old chickens were inoculated intraconjunctivally with the recombinant NDV strain NDFLtag, a derivative of the lentogenic LaSota strain, containing a velogenic cleavage site. When compared with the lentogenic strain only a small effect of the mutation on the pathogenesis in chickens was observed. This study and the observation that the ICPI value of viruses of lentogenic origin containing an artificial velogenic cleavage site is not as high as that of the velogenic strains from which the cleavage site was derived suggests that there must be other factors that contribute to virulence and to the extent of clinical disease.

Several studies have shown that the consequences of an infection are not solely determined by the presence of a multi-basic cleavage site motif in the viral fusion protein. A recent study with an avirulent avian paramyxovirus serotype 2 (APMV-2) virus showed that this virus does not require exogenous protease supplementation for growth in cell culture. In addition, recombinant APMV-2 viruses in which the cleavage site was replaced by that of APMV serotypes 1 to 9 gained in cleavability, replication and syncytium formation in infected cells, but remained avirulent for chickens. Also, a recombinant NDV LaSota virus (NDFLtag), containing a velogenic cleavage site motif, showed an increase in virulence after one passage in chicken brain as determined by an increase in ICPI from 1.3 to 1.7, while sequence analysis of the entire F gene did not show any mutations. Furthermore, some pigeon derived NDV strains, the so-called pigeon paramyxovirus type 1 (PPMV-1), cause minimal disease despite their F proteins having a multiple basic amino acid sequence. However, they do have a virulence potential in chickens that can emerge upon serial passages in these animals. Sequence analysis of such passaged viruses showed that the F protein sequence had not changed and could thus not explain the increase in virulence. This observation has been confirmed using an infectious cDNA clone of PPMV-1 strain AV324 to prove that the low virulence for both chickens and pigeons is an inherent property of this particular virus and is not due to the virus preparation actually consisting of a mixture of low- and high-virulent variants. Furthermore, replacement of the F gene of a virulent NDV strain by that of a non-virulent PPMV-1 strain and vice versa did not affect the virulence of the recipient viruses (Table 1), indicating that the non-virulent phenotype of the PPMV-1 strain must be determined by other factors.

The HN protein is responsible for the attachment of virus particles to sialic acid-containing receptors on cell surfaces and for triggering the fusion activity of the F protein during entry of the virus into the host cell. In addition it acts as a neuraminidase, removing sialic acid from progeny virus particles to prevent viral self-aggregation. Comparison of the nucleotide sequences of NDV HN genes has demonstrated that there are three different HN genotypes resulting in proteins of 571, 577 or 616 aa. The HN protein of 616 aa was detected in some lentogenic strains and appears to be a precursor that needs to be processed into biologically active HN by proteolytic removal of a small glycosylated C-terminal fragment. Because the F and HN proteins are closely associated in the virion membrane and in view of the correlation between proteolytic activation of the F protein and viral virulence, it was suggested that processing of this HN precursor might also affect virulence. However, a study investigating the effect of the length of the HN open reading frame on virulence could not show any correlation.

Several reverse genetics studies have addressed the contribution of HN to virulence either by exchanging genes between strains, by mutating the glycosylation sites, or by mutating specific residues. The results of these studies are, however, not always in agreement and are therefore not conclusive as to the contribution of HN to virulence. In one of these experiments, a recombinant LaSota virus containing the HN protein of the mesogenic Beaudette C strain showed a significant increase in virulence, changing the pathotype of the recombinant virus from lentogenic to mesogenic. In contrast, another study with exactly the same recombinants could not confirm the results of the MDT and ICPI tests, as shown in Table 2. However, this study did show a decrease in IVPI caused by the HN protein when comparing rBC(HN)L with its parent rBC and confirmed the suggestion that the HN protein determines tissue tropism. This also confirmed findings of a previous study in which the HN protein of the low virulent LaSota virus was substituted by that of the velogenic strain Herts or by an HN chimera consisting of the stem region of strain Herts HN and the globular head of that of LaSota, or vice versa. Whereas the ICPI of the resulting recombinants, NDFLtag(HN)H, NDFLtag(HN)LH and NDFLtag(HN)HL (Table 2), did not differ from the parent strain NDFLtag, these recombinants did show a significant increase in IVPI value, suggesting that both the stem region and globular head of the HN protein are involved in determining virus tropism and virulence. The same conclusion could be drawn from a study in which the same chimeric HN genes were used to replace the HN gene of the virulent Herts strain (Table 2).

A similar approach was used by Estevez et al. who created chimeras by exchanging the HN gene of a mesogenic strain by that of a neurotropic or viscerotropic velogenic virus. Introduction of such an HN gene in the NDV Anhinga backbone failed to increase virulence from a mesogenic to a velogenic pathotype when introduced via the ocular infection route in both day-old and 4-week-old chickens. Both studies suggested that NDV virulence is determined multigenically.

In a recent study the role was investigated of the F and HN proteins of two phenotypically contrasting viruses: the moderately virulent NDV virus Beaudette C and the avirulent virus APMV-2. By simultaneously exchanging the F and HN ectodomains between these viruses it was shown that the two contrasting phenotypes correlated with the origin of the F and HN ectodomains when analysed for replication in vitro, syncytium formation, MDT, ICPI, and replication and tropism in 1-day-old and 2-week-old chickens. The authors concluded that these ectodomains together determine cell fusion, tropism, and virulence phenotypes of NDV and APMV-2. Furthermore, the regions of HN that are critical for the species-specific phenotypes include the cytoplasmic tail and stalk domain, but not the globular head domain.

A key amino acid that showed its importance for the biological activity of the HN protein is residue Y526, which is near the sialic acid binding site in the globular head region. Mutation Y526Q resulted in a decrease in viral haemadsorption activity, neuraminidase activity and fusion activity. Furthermore, this mutation had an attenuating effect on the growth kinetics in cell culture, mean death time and the ICPI value. On the other hand, a recent report showed that although a single amino acid substitution I192M, affects both fusion and neuraminidase activity, it had no effect on the virus pathotype.

In many cases proper glycosylation of viral proteins is important for their correct function in the virus life cycle. Modification of HN's N-linked glycosylation sites has been shown to decrease NDV virulence. Since most of the glycosylation sites in the NDV HN protein are well conserved, they seem to play an important role in the biological function of the protein.

5. Immune evasion and virulence

The interferon (IFN) system is the first line of host defence against virus infection. Interferons induce an antiviral state that can inhibit virus replication and control virus spread. Paramyxoviruses have evolved mechanisms to escape or prevent both IFN production and IFN responsive signal transduction to evade or antagonize the innate immune response of its host. Many paramyxovirus IFN evasion activities are mediated by the virus-encoded V protein, which is conserved in the genera of the Paramyxovirinae, with the exception of human parainfluenza virus type 1 (HPIV-1), which lacks an intact V ORF. The NDV V protein is derived from the polycistronic P gene, which is edited during transcription by inserting one or two G residues at the conserved editing locus (AAAAAGGG), thereby generating altogether three P-gene-derived mRNA species. The mRNAs encode the open reading frame (ORF) of P (unedited), the V ORF (+1 frameshift), and the W ORF (+2 frameshift). The IFN-antagonist activity of NDV and many other paramyxoviruses has been mapped to the cysteine-rich C-terminal domain of the V protein, which is highly conserved among several paramyxoviruses.

A recent study showed that the V protein of the mesogenic Beaudette C strain exhibits a greater antagonistic effect on IFN induction in vitro than that of the lentogenic LaSota strain. This might correlate with their different virulence properties in vivo. Previous studies using recombinant NDV that lacked the expression of the V protein already suggested that this protein plays an important role in virulence (Table 3). Its contribution to NDV virulence was demonstrated in chickens and embryonated chicken eggs. Furthermore, its function was investigated in cell culture. NDV mutants that completely or partially lack the V protein or that contain a mutated V protein show severe growth impairment in vitro, while their replication in embryonated chicken eggs is age-dependent. Probably, a reduction in growth of mutant viruses in older embryonated eggs is due to maturation of the host innate immune system and, most likely, the inability of the mutant viruses to counteract the IFN response, which is better developed in older embryos.

It has been shown that viruses with mutated V proteins, in contrast to their parent viruses, are unable to degrade the STAT1 protein, which is an important element of the interferon signalling pathway. Furthermore, in vitro experiments have shown that these viruses have an increased rate of apoptosis. In addition, in vivo studies showed that the apoptotic rates corresponded to the severity of the clinicopathological disease of different strains. The results obtained in studies on the V protein of NDV are in agreement with in vivo studies of measles virus and Sendai virus pathogenesis, which showed that deletion of the V protein attenuates viral virulence.

No studies have been published in which the V genes have been exchanged between different NDV strains, as has for instance been done for the F, HN, or L genes. In an unpublished study, the V proteins of the low virulent LaSota virus and the highly virulent Herts virus were compared by expressing them in a V-negative Herts backbone with an intact P ORF. The V genes were inserted between the P and M ORFs. No differences in ICPI value between the two recombinants were observed (M. Tacken, O. de Leeuw and L. Cornelissen, personal communication). Altogether, the studies mentioned clearly indicate that the V protein is essential for survival and replication of the virus in its host. However, more studies, especially using the natural infection route, must be performed to examine whether the V protein is also involved in determining differences in virulence between NDV strains.

6. Replication and virulence

A correlation between virulence and the efficiency of viral replication has been observed for many viruses. Although not fully understood, it is quite conceivable that higher levels of viral replication result in more virus production which may overwhelm the host immune response, hence causing enhanced pathogenesis. It has been reported for NDV that reduced levels of RNA synthesis are associated with reduced virulence. For several other paramyxoviruses such as measles virus, respiratory syncytial virus and parainfluenza virus, virus attenuation has been associated with mutations in components of the replication complex. For influenza virus the viral polymerase proteins PB2 and PA are known to contribute to virulence. In addition, transcriptional and translation control signals may also modulate virulence by controlling protein expression as has, for instance, been described for vesicular stomatitis virus, measles virus, canine distemper virus and NDV.

The involvement of the NP, P and L replication proteins in NDV virulence has been examined by generating chimeric viruses in which genes were exchanged between strains of different pathotypes. In one of these studies a recombinant Beaudette C virus containing the L gene of strain LaSota was shown to replicate to higher levels both in vitro and in vivo and to be slightly more virulent than its parental virus in one-day-old chickens (Table 4). However, no effect was found for the NP and P proteins. In contrast, in our own study all three proteins that make up the viral replication complex (NP, P and L) were found to play a significant role in determining the virulence of NDV. By simultaneously exchanging all genes for the replication proteins between strains Herts and AV324, the virulent Herts virus became significantly attenuated, whereas the low virulent AV324 became much more virulent (Table 4). This was also consistent with in vitro studies, which showed that the replication proteins of Herts are more active than those of AV324. However, the role of the individual replication proteins remained less conclusive. One possible explanation is that the individual Herts replication proteins are inherently more active but that optimal activity is dependent on the presence of the cognate interaction partners. This feature has also been previously observed for the recovered influenza 1918 virus, where the gene segments show a synergistic effect. Another possible explanation might be that the proteins of the two investigated viruses originate from two distinct phylogenetic lineages that are less compatible.

We studied the adaptation of a PPMV-1 strain to chickens during brain passage. After five passages 3 mutations became dominant in the virus population, two in the L protein (N1564S and V1694E) and one in the P protein (N37D). These mutations resulted in more efficient replication both in vitro and in vivo, indicating that virulence of PPMV-1 for chickens is directly related to the efficiency of virus replication. Further investigations will be needed to unravel the exact mechanisms of viral transcription, replication and host-interaction and their effect on virulence.

The viral matrix (M) protein has been identified as another regulator involved in viral replication. While the M protein is considered to be the central organizer of viral morphogenesis and budding, it has also been found to interact with the replication complex and to thereby affect viral transcription and/or replication, as has been shown for rhabdoviruses and some paramyxoviruses. With NP as its most likely binding partner, the M protein associates with the nucleocapsid. Upon viral entry of the target cell, the nucleocapsid dissociates from the M protein and is released into the cytoplasm where transcription can occur. The interaction of M with the nucleocapsid might affect transcription and consequently may have an effect on replication. Furthermore, it is known that the M protein traffics between the cytoplasm and the nucleus during the viral infection cycle. It has been suggested that the presence of M in the nucleus may result in the inhibition of host cell functions, although this has not yet been confirmed for NDV. Replacement of the M protein in strain Herts by that of strain AV324 significantly decreased the ICPI value, however, the opposite was not the case, as shown in Table 5.

7. Non-coding regions

Untranslated regions (UTRs) in viruses have been shown to play a role in the regulation of viral transcription and translation. In measles virus and canine distemper virus, the long 3'UTR of M and 5'UTR of F play important roles in replication and virulence of the virus. A 6 nt insert in the 5'UTR of the NP gene divides the NDV class II viruses into two groups, namely one with a genome length of 15 186 nt and another with a genome length of 15 192 nt. The fact that both groups harbour pathogenic viruses suggests that this 6 nt insert does not play a major role in virulence.

Deletion of the entire 5'UTR of the HN gene was shown to affect transcription and translation of the HN mRNA and thereby virulence. Furthermore, each UTR seems to be specific for a particular position on the genome and for its associated gene.

The sizes of the intergenic sequences (IGSs), i.e. the number of nucleotides between the transcription end-box and transcription start-box, of consecutive genes of NDV vary from a single nt for the first three gene boundaries to 31 nt for the F-HN and 47 nt for the HN-L boundaries, respectively. A study has shown that although NDV can tolerate an IGS length of at least 365 nt, the extended lengths of IGSs down-regulated the transcription of the downstream gene. Furthermore, all viruses that had extended or decreased IGS lengths were attenuated in embryonated chicken eggs, day-old chicks and 6-week-old chickens. While it is clear that the above described genetic modifications have an effect on virulence, it is questionable whether the genomic regions and sequences involved also play a role in determining differences in virulence between naturally occurring NDV strains. The sizes of the IGSs and UTRs of NDV are conserved whereas the nucleotide sequence of these regions may vary to some extent, which is not unexpected for non-coding regions.

8. Concluding remarks

More and more studies illustrate that virulence is a complex trait that is determined by multiple genetic factors. For NDV, the multi-basic amino acid cleavage motif in the F protein is an absolute prerequisite for virulence. In addition, other factors are critically involved in determining virulence, as shown in this review and summarised in Figure 1. However, we must note that the contribution of these factors to virulence may be dependent on the particular virus strain used. For instance, the use of the atypical PPMV-1 strain AV324 has revealed significant effects of the viral replication machinery on virulence. These effects would have been much more difficult to show when using a velogenic strain in which the contribution of the replication complex is probably relatively low compared to that of the F protein cleavage site. Another point to consider is the use of the ICPI as a readout parameter of virulence. As argued above, this test uses an artificial inoculation route and as a consequence it may be questioned whether the results obtained with this test are always relevant for the natural situation. Although this test is often compulsory to determine whether an isolate is virulent or not, its sensitivity may be insufficient to detect subtle differences in virulence.

Many questions still remain concerning the molecular mechanisms used by NDV to regulate tropism, transcription and translation, interference with the host defence machinery, and how they affect virulence. Nevertheless, the studies summarised in this review have contributed significantly to our understanding of the biology of NDV and can serve as an important guide for future research on the molecular principles that determine its virulence.

9. Acknowledgements

The authors would like to thank MGJ Tacken, OS de Leeuw and LA Cornelissen for sharing their unpublished data.

10. Competing interests

The authors declare that they have no competing interests.

11. Authors' contributions

JD developed the structural design of the review and drafted the manuscript. GK and PR reviewed the manuscript. BP supervised the study, and reviewed the manuscript. All authors read and approved the final manuscript.

References 126

  1. 1.

    Lancaster JE A history of Newcastle disease with comments on its economic effectsWorld Poultry Sci J1976 32167175

    Not in our library10.1079/wps19760001

  2. 2.

    Spradbrow PB Alexander DJGeographical distributionNewcastle Disease1988 Boston: Kluwer Academic Publishers247255

    Not in our library

  3. 3.

    Kaleta EF Baldauf C Alexander DJNewcastle disease in free-living and pet birdsNewcastle Disease1988 Boston: Kluwer Academic Publishers197246

    Not in our library

  4. 4.

    Doyle TM A hitherto unrecorded disease of fowls due to a filter-passing virusJ Comp Pathol1927 40144169

    Not in our library

  5. 5.

    Kraneveld FC A poultry disease in the Duch East indiesNed-Ind Bl Diergeneesk1926 38488450

    Not in our library

  6. 6.

    Beard CW Hanson RP Hofstad MS, Barnes HJ, Calnek BW, Reid WM, Yoder HWNewcastle diseaseDiseases of Poultry1981 EightAmes, Iowa, USA: Iowa State University Press452470

    Not in our library

  7. 7.

    Alexander DJ Calnek BW, Barnes HJ, Beard CW, McDougald LR, Saif YMNewcastle disease and other avian Paramyxoviridae infectionsDisease of poultry1997 10Ames, Iowa: Iowa State University Press541570

    Not in our library

  8. 8.

    Hanson RP Hitchner SB, Domermuth CH, Purchase HG, Williams JENewcastle diseaseIsolation and Identification of Avian Pathogens1975 Kennett Square: American Association of Avian Pathologists160173

    Not in our library

  9. 9.

    Rott R Klenk HD Alexander DJMolecular basis of infectivity and pathogenicity of Newcastle disease virusNewcastle disease1988 Boston: Kluwer Academic Publishers98112

    Not in our library

  10. 10.

    Schloer GM Hanson RP Relationship of plaque size and virulence for chickens of 14 representative Newcastle disease virus strainsJ Virol1968 24047

    Not in our library10.1128/jvi.2.1.40-47.1968

  11. 11.

    Reeve P Poste G Studies on the cytopathogenicity of Newcastle disease virus: relation between virulence, polykaryocytosis and plaque sizeJ Gen Virol1971 111724

    Not in our library10.1099/0022-1317-11-1-17

  12. 12.

    Yan Y Samal SK Role of intergenic sequences in Newcastle disease virus RNA transcription and pathogenesisJ Virol2008 8213231331

    Not in our library10.1128/jvi.01989-07

  13. 13.

    Dortmans JCFM Rottier PJM Koch G Peeters BPH The viral replication complex is associated with the virulence of Newcastle disease virusJ Virol2010 841011310120

    Not in our library10.1128/jvi.00097-10

  14. 14.

    Horimoto T Kawaoka Y Biologic effects of introducing additional basic amino acid residues into the hemagglutinin cleavage site of a virulent avian influenza virusVirus Res1997 503540

    Not in our library10.1016/s0168-1702(97)00050-6

  15. 15.

    Moore BD Balasuriya UB Hedges JF MacLachlan NJ Growth characteristics of a highly virulent, a moderately virulent, and an avirulent strain of equine arteritis virus in primary equine endothelial cells are predictive of their virulence to horsesVirology2002 2983944

    Not in our library10.1006/viro.2002.1466

  16. 16.

    Tearle JP Smith KC Platt AJ Hannant D Davis-Poynter NJ Mumford JA In vitro characterisation of high and low virulence isolates of equine herpesvirus-1 and -4Res Vet Sci2003 758386

    Not in our library10.1016/s0034-5288(03)00031-6

  17. 17.

    Hanson RP Brandly CA Identification of vaccine strains of Newcastle disease virusScience (New York, NY)1955 122156157

    Not in our library

  18. 18.

    Alexander DJ Alexander DJNewcastle disease diagnosisNewcastle Disease1988 Boston: Kluwer Academic Publishers147160

    Not in our library

  19. 19.

    Alexander DJ Newcastle disease. Chapter 2.3.14Manual of Diagnostic Tests and Vaccines for Terrestrial Animals2009 Paris, France: OIE, the World Organisation for Animal Health576589

    Not in our library

  20. 20.

    Pearson JE Senne DA Alexander DJ Taylor WD Peterson LA Russell PH Characterization of Newcastle disease virus (avian paramyxovirus-1) isolated from pigeonsAvian Dis1987 31105111

    Not in our library10.2307/1590781

  21. 21.

    Alexander DJ Gough RE Saif YM, Barnes HJ, Fadly AM, Glisson JR, McDougald LR, Swayne DENewcastle disease, other avian paramyxoviruses and pneumovirus infectionsDiseases of Poultry2003 11Iowa State University Press USA6392

    Not in our library

  22. 22.

    Terregino C Capua I Capua I, Alexander DJConventional diagnosis of Newcastle disease virus infectionAvian Influenza and Newcaslte Disease2009 Milan: Springer-Verlag123125

    Not in our library

  23. 23.

    Susta L Miller PJ Afonso CL Brown CC Clinicopathological characterization in poultry of three strains of Newcastle disease virus isolated from recent outbreaksVet Pathol2011 48349360

    Not in our library10.1177/0300985810375806

  24. 24.

    Wakamatsu N King DJ Seal BS Samal SK Brown CC The pathogenesis of Newcastle disease: a comparison of selected Newcastle disease virus wild-type strains and their infectious clonesVirology2006 353333343

    Not in our library10.1016/j.virol.2006.06.013

  25. 25.

    Wakamatsu N King DJ Seal BS Peeters BP Brown CC The effect on pathogenesis of Newcastle disease virus LaSota strain from a mutation of the fusion cleavage site to a virulent sequenceAvian Dis2006 50483488

    Not in our library10.1637/7515-020706r.1

  26. 26.

    Huang Z Krishnamurthy S Panda A Samal SK Newcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonistJ Virol2003 7786768685

    Not in our library10.1128/jvi.77.16.8676-8685.2003

  27. 27.

    Huang Z Panda A Elankumaran S Govindarajan D Rockemann DD Samal SK The hemagglutinin-neuraminidase protein of Newcastle disease virus determines tropism and virulenceJ Virol2004 7841764184

    Not in our library10.1128/jvi.78.8.4176-4184.2004

  28. 28.

    Panda A Elankumaran S Krishnamurthy S Huang Z Samal SK Loss of N-linked glycosylation from the hemagglutinin-neuraminidase protein alters virulence of Newcastle disease virusJ Virol2004 7849654975

    Not in our library10.1128/jvi.78.10.4965-4975.2004

  29. 29.

    Mayo MA A summary of taxonomic changes recently approved by ICTVArch Virol2002 14716551663

    Not in our library10.1007/s007050200039

  30. 30.

    Czeglédi A Ujvári D Somogyi E Wehmann E Werner O Lomniczi B Third genome size category of avian paramyxovirus serotype 1 (Newcastle disease virus) and evolutionary implicationsVirus Res2006 1203648

    Not in our library10.1016/j.virusres.2005.11.009

  31. 31.

    Steward M Vipond IB Millar NS Emmerson PT RNA editing in Newcastle disease virusJ Gen Virol1993 7425392547

    Not in our library10.1099/0022-1317-74-12-2539

  32. 32.

    Lamb RA Parks GD Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SEParamyxoviridae: the viruses and their replicationFields Virology2007 5Philadelphia, PA: Lippincott Williams & Wilkins14491496

    Not in our library

  33. 33.

    Curran J Reexamination of the Sendai virus P protein domains required for RNA synthesis: a possible supplemental role for the P proteinVirology1996 221130140

    Not in our library10.1006/viro.1996.0359

  34. 34.

    Curran J Marq JB Kolakofsky D The Sendai virus nonstructural C proteins specifically inhibit viral mRNA synthesisVirology1992 189647656

    Not in our library10.1016/0042-6822(92)90588-g

  35. 35.

    Horikami SM Curran J Kolakofsky D Moyer SA Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitroJ Virol1992 6649014908

    Not in our library10.1128/jvi.66.8.4901-4908.1992

  36. 36.

    Poch O Blumberg BM Bougueleret L Tordo N Sequence comparison of five polymerases (L proteins) of unsegmented negative-strand RNA viruses: theoretical assignment of functional domainsJ Gen Virol1990 7111531162

    Not in our library10.1099/0022-1317-71-5-1153

  37. 37.

    Sidhu MS Menonna JP Cook SD Dowling PC Udem SA Canine distemper virus L gene: sequence and comparison with related virusesVirology1993 1935065

    Not in our library10.1006/viro.1993.1102

  38. 38.

    Harrison MS Sakaguchi T Schmitt AP Paramyxovirus assembly and budding: building particles that transmit infectionsInt J Biochem Cell Biol2010 4214161429

    Not in our library10.1016/j.biocel.2010.04.005

  39. 39.

    Takimoto T Portner A Molecular mechanism of paramyxovirus buddingVirus Res2004 106133145

    Not in our library10.1016/j.virusres.2004.08.010

  40. 40.

    Conzelmann KK Genetic manipulation of non-segmented negative-strand RNA virusesJ Gen Virol1996 77381389

    Not in our library10.1099/0022-1317-77-3-381

  41. 41.

    Palese P Zheng H Engelhardt OG Pleschka S Garcia-Sastre A Negative-strand RNA viruses: genetic engineering and applicationsProc Natl Acad Sci USA1996 931135411358

    Not in our library10.1073/pnas.93.21.11354

  42. 42.

    Huang Z Krishnamurthy S Panda A Samal SK High-level expression of a foreign gene from the most 3'-proximal locus of a recombinant Newcastle disease virusJ Gen Virol2001 8217291736

    Not in our library10.1099/0022-1317-82-7-1729

  43. 43.

    Peeters BP de Leeuw OS Koch G Gielkens AL Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulenceJ Virol1999 7350015009

    Not in our library10.1128/jvi.73.6.5001-5009.1999

  44. 44.

    Römer-Oberdörfer A Mundt E Mebatsion T Buchholz UJ Mettenleiter TC Generation of recombinant lentogenic Newcastle disease virus from cDNAJ Gen Virol1999 8029872995

    Not in our library10.1099/0022-1317-80-11-2987

  45. 45.

    Nakaya T Cros J Park MS Nakaya Y Zheng H Sagrera A Villar E Garcia-Sastre A Palese P Recombinant Newcastle disease virus as a vaccine vectorJ Virol2001 751186811873

    Not in our library10.1128/jvi.75.23.11868-11873.2001

  46. 46.

    Dortmans JCFM Koch G Rottier PJM Peeters BPH Virulence of pigeon paramyxovirus type 1 does not always correlate with the cleavability of its fusion proteinJ Gen Virol2009 9027462750

    Not in our library10.1099/vir.0.014118-0

  47. 47.

    Krishnamurthy S Huang Z Samal SK Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuationVirology2000 278168182

    Not in our library10.1006/viro.2000.0618

  48. 48.

    Estevez C King D Seal B Yu Q Evaluation of Newcastle disease virus chimeras expressing the Hemagglutinin-Neuraminidase protein of velogenic strains in the context of a mesogenic recombinant virus backboneVirus Res2007 129182190

    Not in our library10.1016/j.virusres.2007.07.008

  49. 49.

    De Leeuw OS Koch G Hartog L Ravenshorst N Peeters BP Virulence of Newcastle disease virus is determined by the cleavage site of the fusion protein and by both the stem region and globular head of the haemagglutinin-neuraminidase proteinJ Gen Virol2005 8617591769

    Not in our library10.1099/vir.0.80822-0

  50. 50.

    Liu YL Hu SL Zhang YM Sun SJ Römer-Oberdörfer A Veits J Wu YT Wan HQ Liu XF Generation of a velogenic Newcastle disease virus from cDNA and expression of the green fluorescent proteinArch Virol2007 15212411249

    Not in our library10.1007/s00705-007-0961-x

  51. 51.

    Morales JA Merino E Garcia D Ortega R Christy N Marrufo D Ducio E Cruz M Absalon AE Aortés DV Jackwood M, Miller PJ, Hein R, Smith JDevelopment of a recombinant Newcastle disease virus vaccine and Its efficacy in a broiler farm1st International Avian Respiratory Disease Conference; May 15-18, 20112011 Athens, Georgia, USA3134

    Not in our library

  52. 52.

    Duarte EA Novella IS Weaver SC Domingo E Wain-Hobson S Clarke DK Moya A Elena SF de la Torre JC Holland JJ RNA virus quasispecies: significance for viral disease and epidemiologyInfect Agents Dis1994 3201214

    Not in our library

  53. 53.

    Duarte EA Novella IS Ledesma S Clarke DK Moya A Elena SF Domingo E Holland JJ Subclonal components of consensus fitness in an RNA virus cloneJ Virol1994 6842954301

    Not in our library10.1128/jvi.68.7.4295-4301.1994

  54. 54.

    Klenk H-D Garten W Host cell proteases controlling virus pathogenicityTrends Microbiol1994 23943

    Not in our library10.1016/0966-842x(94)90123-6

  55. 55.

    Garten W Berk W Nagai Y Rott R Klenk HD Mutational changes of the protease susceptibility of glycoprotein F of Newcastle disease virus: effects on pathogenicityJ Gen Virol1980 50135147

    Not in our library10.1099/0022-1317-50-1-135

  56. 56.

    Madansky CH Bratt MA Noncytopathic mutants of Newcastle disease virusJ Virology1978 26724729

    Not in our library10.1128/jvi.26.3.724-729.1978

  57. 57.

    Nagai Y Klenk HD Activation of precursors to both glycoporteins of Newcastle disease virus by proteolytic cleavageVirology1977 77125134

    Not in our library10.1016/0042-6822(77)90412-3

  58. 58.

    Nagai Y Klenk HD Rott R Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virusVirology1976 72494508

    Not in our library10.1016/0042-6822(76)90178-1

  59. 59.

    Choppin PW Scheid A The role of viral glycoproteins in adsorption, penetration, and pathogenicity of virusesRev Infect Dis1980 24061

    Not in our library10.1093/clinids/2.1.40

  60. 60.

    Glickman RL Syddall RJ Iorio RM Sheehan JP Bratt MA Quantitative basic residue requirements in the cleavage-activation site of the fusion glycoprotein as a determinant of virulence for Newcastle disease virusJ Virol1988 62354356

    Not in our library10.1128/jvi.62.1.354-356.1988

  61. 61.

    Ogasawara T Gotoh B Suzuki H Asaka J Shimokata K Rott R Nagai Y Expression of factor X and its significance for the determination of paramyxovirus tropism in the chick embryoEMBO J1992 11467472

    Not in our library10.1002/j.1460-2075.1992.tb05076.x

  62. 62.

    Panda A Huang Z Elankumaran S Rockemann DD Samal SK Role of fusion protein cleavage site in the virulence of Newcastle disease virusMicrobial Pathogen2004 36110

    Not in our library10.1016/j.micpath.2003.07.003

  63. 63.

    Römer-Oberdörfer A Werner O Veits J Mebatsion T Mettenleiter TC Contribution of the length of the HN protein and the sequence of the F protein cleavage site to Newcastle disease virus pathogenicityJ Gen Virol2003 8431213129

    Not in our library10.1099/vir.0.19416-0

  64. 64.

    Hu S Ma H Wu Y Liu W Wang X Liu Y Liu X A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse geneticsVaccine2009 27904910

    Not in our library10.1016/j.vaccine.2008.11.091

  65. 65.

    Samal S Kumar S Khattar SK Samal SK A single amino acid change, Q114R, in the cleavage-site sequence of Newcastle disease virus fusion protein attenuates viral replication and pathogenicityJ Gen Virol2011 9223332338

    Not in our library10.1099/vir.0.033399-0

  66. 66.

    Subbiah M Khattar SK Collins PL Samal SK Mutations in the fusion protein cleavage site of avian paramyxovirus serotype 2 increase cleavability and syncytium formation but do not increase viral virulence in chickensJ Virol2011 8553945405

    Not in our library10.1128/jvi.02696-10

  67. 67.

    De Leeuw OS Hartog L Koch G Peeters BP Effect of fusion protein cleavage site mutations on virulence of Newcastle disease virus: non-virulent cleavage site mutants revert to virulence after one passage in chicken brainJ Gen Virol2003 84475484

    Not in our library10.1099/vir.0.18714-0

  68. 68.

    Alexander DJ Parsons G Avian paramyxovirus type 1 infections of racing pigeons: 2 pathogenicity experiments in pigeons and chickensVet Rec1984 114466469

    Not in our library10.1136/vr.114.19.466

  69. 69.

    Collins MS Strong I Alexander DJ Evaluation of the molecular basis of pathogenicity of the variant Newcastle disease viruses termed "pigeon PMV-1 viruses"Arch Virol1994 134403411

    Not in our library10.1007/bf01310577

  70. 70.

    Kommers GD King DJ Seal BS Brown CC Virulence of pigeon-origin Newcastle disease virus isolates for domestic chickensAvian Dis2001 45906921

    Not in our library10.2307/1592870

  71. 71.

    Kommers GD King DJ Seal BS Brown CC Virulence of six heterogeneous-origin Newcastle disease virus isolates before and after sequential passages in domestic chickensAvian Pathol2003 328193

    Not in our library10.1080/0307945021000070750

  72. 72.

    Collins MS Strong I Alexander DJ Pathogenicity and phylogenetic evaluation of the variant Newcastle disease viruses termed "pigeon PMV-1 viruses" based on the nucleotide sequence of the fusion protein geneArch Virol1996 141635647

    Not in our library10.1007/bf01718322

  73. 73.

    Dortmans JCFM Koch G Rottier PJM Peeters BPH A comparative infection study of pigeon and avian paramyxovirus type 1 viruses in pigeons: evaluation of clinical signs, virus shedding and seroconversionAvian Pathol2011 40125130

    Not in our library10.1080/03079457.2010.542131

  74. 74.

    Sato H Hattori S Ishida N Imamura Y Kawakita M Nucleotide sequence of the hemagglutinin-neuraminidase gene of Newcastle disease virus avirulent strain D26: evidence for a longer coding region with a carboxyl terminal extension as compared to virulent strainsVirus Res1987 8217232

    Not in our library10.1016/0168-1702(87)90017-7

  75. 75.

    Gorman JJ Nestorowicz A Mitchell SJ Corino GL Selleck PW Characterization of the sites of proteolytic activation of Newcastle disease virus membrane glycoprotein precursorsJ Biol Chem1988 2631252212531

    Not in our library

  76. 76.

    Garten W Kohama T Klenk HD Proteolytic activation of the haemagglutinin-neuraminidase of Newcastle disease virus involves loss of a glycopeptideJ Gen Virol1980 51207211

    Not in our library10.1099/0022-1317-51-1-207

  77. 77.

    Susta L Miller PJ Afonso CL Estevez C Yu Q Zhang J Brown CC Pathogenicity evaluation of different Newcastle disease virus chimeras in 4-week-old chickensTrop Anim Health Prod2010 4217851795

    Not in our library10.1007/s11250-010-9638-7

  78. 78.

    Kim SH Subbiah M Samuel AS Collins PL Samal SK Roles of the fusion and hemagglutinin-neuraminidase proteins in replication, tropism, and pathogenicity of avian paramyxovirusesJ Virol2011 8585828596

    Not in our library10.1128/jvi.00652-11

  79. 79.

    Khattar SK Yan Y Panda A Collins PL Samal SK A Y526Q mutation in the Newcastle disease virus HN protein reduces its functional activities and attenuates virus replication and pathogenicityJ Virol2009 8377797782

    Not in our library10.1128/jvi.00536-09

  80. 80.

    Estevez C King DJ Luo M Yu Q A single amino acid substitution in the haemagglutinin-neuraminidase protein of Newcastle disease virus results in increased fusion promotion and decreased neuraminidase activities without changes in virus pathotypeJ Gen Virol2011 92544551

    Not in our library10.1099/vir.0.027540-0

  81. 81.

    Vigerust DJ Shepherd VL Virus glycosylation: role in virulence and immune interactionsTrends Microbiol2007 15211218

    Not in our library10.1016/j.tim.2007.03.003

  82. 82.

    Fontana JM Bankamp B Rota PA Inhibition of interferon induction and signaling by paramyxovirusesImmunol Rev2008 2254667

    Not in our library10.1111/j.1600-065x.2008.00669.x

  83. 83.

    Goodbourn S Randall RE The regulation of type I interferon production by paramyxovirusesJ Interf Cytok Res2009 29539547

    Not in our library10.1089/jir.2009.0071

  84. 84.

    Ramachandran A Horvath CM Paramyxovirus disruption of interferon signal transduction: STATus reportJ Interf Cytok Res2009 29531538

    Not in our library10.1089/jir.2009.0070

  85. 85.

    Matsuoka Y Curran J Pelet T Kolakofsky D Ray R Compans RW The P gene of human parainfluenza virus type 1 encodes P and C proteins but not a cysteine-rich V proteinJ Virol1991 6534063410

    Not in our library10.1128/jvi.65.6.3406-3410.1991

  86. 86.

    Thomas SM Lamb RA Paterson RG Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5Cell1988 54891902

    Not in our library10.1016/s0092-8674(88)91285-8

  87. 87.

    Park MS Shaw ML Munoz-Jordan J Cros JF Nakaya T Bouvier N Palese P Garcia-Sastre A Basler CF Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteinsJ Virol2003 7715011511

    Not in our library10.1128/jvi.77.2.1501-1511.2003

  88. 88.

    Childs K Stock N Ross C Andrejeva J Hilton L Skinner M Randall R Goodbourn S mda-5, but not RIG-I, is a common target for paramyxovirus V proteinsVirology2007 359190200

    Not in our library10.1016/j.virol.2006.09.023

  89. 89.

    Alamares JG Elankumaran S Samal SK Iorio RM The interferon antagonistic activities of the V proteins from two strains of Newcastle disease virus correlate with their known virulence propertiesVirus Res2010 147153157

    Not in our library10.1016/j.virusres.2009.10.020

  90. 90.

    Mebatsion T Verstegen S De Vaan LT Römer-Oberdörfer A Schrier CC A recombinant newcastle disease virus with low-level V protein expression is immunogenic and lacks pathogenicity for chicken embryosJ Virol2001 75420428

    Not in our library10.1128/jvi.75.1.420-428.2001

  91. 91.

    Park MS Garcia-Sastre A Cros JF Basler CF Palese P Newcastle disease virus V protein is a determinant of host range restrictionJ Virol2003 7795229532

    Not in our library10.1128/jvi.77.17.9522-9532.2003

  92. 92.

    Sekellick MJ Biggers WJ Marcus PI Development of the interferon system. I. In chicken cells development in ovo continues on time in vitroIn Vitro Cell Dev Biol1990 269971003

    Not in our library10.1007/bf02624475

  93. 93.

    Horvath CM Weapons of STAT destructionEur J Biochem2004 27146214628

    Not in our library10.1111/j.1432-1033.2004.04425.x

  94. 94.

    Harrison L Brown C Afonso C Zhang J Susta L Early occurrence of apoptosis in lymphoid tissues from chickens infected with strains of newcastle disease virus of varying virulenceJ Comp Pathol2011 145327335

    Not in our library10.1016/j.jcpa.2011.03.005

  95. 95.

    Huang C Kiyotani K Fujii Y Fukuhara N Kato A Nagai Y Yoshida T Sakaguchi T Involvement of the zinc-binding capacity of Sendai virus V protein in viral pathogenesisJ Virol2000 7478347841

    Not in our library10.1128/jvi.74.17.7834-7841.2000

  96. 96.

    Patterson JB Thomas D Lewicki H Billeter MA Oldstone MB V and C proteins of measles virus function as virulence factors in vivoVirology2000 2678089

    Not in our library10.1006/viro.1999.0118

  97. 97.

    Madansky CH Bratt MA Noncytopathic mutants of Newcastle disease virus are defective in virus-specific RNA synthesisJ Virol1981 37317327

    Not in our library10.1128/jvi.37.1.317-327.1981

  98. 98.

    Bankamp B Kearney SP Liu X Bellini WJ Rota PA Activity of polymerase proteins of vaccine and wild-type measles virus strains in a minigenome replication assayJ Virol2002 7670737081

    Not in our library10.1128/jvi.76.14.7073-7081.2002

  99. 99.

    Takeda M Kato A Kobune F Sakata H Li Y Shioda T Sakai Y Asakawa M Nagai Y Measles virus attenuation associated with transcriptional impediment and a few amino acid changes in the polymerase and accessory proteinsJ Virol1998 7286908696

    Not in our library10.1128/jvi.72.11.8690-8696.1998

  100. 100.

    Murphy BR Collins PL Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse geneticsJ Clin Invest2002 1102127

    Not in our library10.1172/jci16077

  101. 101.

    Skiadopoulos MH Durbin AP Tatem JM Wu SL Paschalis M Tao T Collins PL Murphy BR Three amino acid substitutions in the L protein of the human parainfluenza virus type 3 cp45 live attenuated vaccine candidate contribute to its temperature-sensitive and attenuation phenotypesJ Virol1998 7217621768

    Not in our library10.1128/jvi.72.3.1762-1768.1998

  102. 102.

    Salomon R Franks J Govorkova EA Ilyushina NA Yen H-L Hulse-Post DJ Humberd J Trichet M Rehg JE Webby RJ Webster RG Hoffmann E The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04J Exp Med2006 203689697

    Not in our library10.1084/jem.20051938

  103. 103.

    Stech J Klenk H-D, Matrosovich MN, Stech JInfluenza A Virus Polymerase: A Determinant of Host Range and PathogenicityAvian Influenza2008 27Basel: Karger187194[Doerr HW (Series Editor): Monographs in Virology]

    Not in our library

  104. 104.

    Rolling T Koerner I Zimmermann P Holz K Haller O Staeheli P Kochs G Adaptive mutations resulting in enhanced polymerase activity contribute to high virulence of influenza A virus in miceJ Virol2009 8366736680

    Not in our library10.1128/jvi.00212-09

  105. 105.

    Song MS Pascua PN Lee JH Baek YH Lee OJ Kim CJ Kim H Webby RJ Webster RG Choi YK The polymerase acidic protein gene of influenza a virus contributes to pathogenicity in a mouse modelJ Virol2009 831232512335

    Not in our library10.1128/jvi.01373-09

  106. 106.

    Barr JN Whelan SP Wertz GW Role of the intergenic dinucleotide in vesicular stomatitis virus RNA transcriptionJ Virol1997 7117941801

    Not in our library10.1128/jvi.71.3.1794-1801.1997

  107. 107.

    Stillman EA Whitt MA The length and sequence composition of vesicular stomatitis virus intergenic regions affect mRNA levels and the site of transcript initiationJ Virol1998 7255655572

    Not in our library10.1128/jvi.72.7.5565-5572.1998

  108. 108.

    Kim SH Samal SK Role of untranslated regions in regulation of gene expression, replication, and pathogenicity of Newcastle disease virus expressing green fluorescent proteinJ Virol2010 8426292634

    Not in our library10.1128/jvi.02049-09

  109. 109.

    Yan Y Rout SN Kim SH Samal SK Role of untranslated regions of the hemagglutinin-neuraminidase gene in replication and pathogenicity of Newcastle disease virusJ Virol2009 8359435946

    Not in our library10.1128/jvi.00188-09

  110. 110.

    Parks CL Lerch RA Walpita P Wang H-P Sidhu MS Udem SA Analysis of the noncoding regions of measles virus strains in the Edmonston vaccine lineageJ Virol2001 75921933

    Not in our library10.1128/jvi.75.2.921-933.2001

  111. 111.

    Anderson DE von Messling V Region between the canine distemper virus M and F genes modulates virulence by controlling fusion protein expressionJ Virol2008 821051010518

    Not in our library10.1128/jvi.01419-08

  112. 112.

    Rout SN Samal SK The large polymerase protein is associated with the virulence of Newcastle disease virusJ Virol2008 8278287836

    Not in our library10.1128/jvi.00578-08

  113. 113.

    Kash JC Tumpey TM Proll SC Carter V Perwitasari O Thomas MJ Basler CF Palese P Taubenberger JK Garcia-Sastre A Swayne DE Katze MG Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virusNature2006 443578581

    Not in our library10.1038/nature05181

  114. 114.

    Aldous EW Mynn JK Banks J Alexander DJ A molecular epidemiological study of avian paramyxovirus type 1 (Newcastle disease virus) isolates by phylogenetic analysis of a partial nucleotide sequence of the fusion protein geneAvian Pathol2003 32239256

    Not in our library10.1080/030794503100009783

  115. 115.

    Dortmans JCFM Rottier PJM Koch G Peeters BPH Passaging of a Newcastle disease virus pigeon variant in chickens results in selection of viruses with mutations in the polymerase complex enhancing virus replication and virulenceJ Gen Virol2011 92336345

    Not in our library10.1099/vir.0.026344-0

  116. 116.

    Li D Jans DA Bardin PG Meanger J Mills J Ghildyal R Association of respiratory syncytial virus M protein with viral nucleocapsids is mediated by the M2-1 proteinJ Virol2008 8288638870

    Not in our library10.1128/jvi.00343-08

  117. 117.

    Ghildyal R Mills J Murray M Vardaxis N Meanger J Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cellsJ Gen Virol2002 83753757

    Not in our library10.1099/0022-1317-83-4-753

  118. 118.

    Suryanarayana K Baczko K ter Meulen V Wagner RR Transcription inhibition and other properties of matrix proteins expressed by M genes cloned from measles viruses and diseased human brain tissueJ Virol1994 6815321543

    Not in our library10.1128/jvi.68.3.1532-1543.1994

  119. 119.

    Finke S Mueller-Waldeck R Conzelmann KK Rabies virus matrix protein regulates the balance of virus transcription and replicationJ Gen Virol2003 8416131621

    Not in our library10.1099/vir.0.19128-0

  120. 120.

    Iwasaki M Takeda M Shirogane Y Nakatsu Y Nakamura T Yanagi Y The matrix protein of measles virus regulates viral RNA synthesis and assembly by interacting with the nucleocapsid proteinJ Virol2009 831037410383

    Not in our library10.1128/jvi.01056-09

  121. 121.

    Ogino T Iwama M Ohsawa Y Mizumoto K Interaction of cellular tubulin with Sendai virus M protein regulates transcription of viral genomeBiochem Biophys Res Commun2003 311283293

    Not in our library10.1016/j.bbrc.2003.09.205

  122. 122.

    Pantua HD McGinnes LW Peeples ME Morrison TG Requirements for the assembly and release of Newcastle disease virus-like particlesJ Virol2006 801106211073

    Not in our library10.1128/jvi.00726-06

  123. 123.

    Coleman NA Peeples ME The matrix protein of Newcastle disease virus localizes to the nucleus via a bipartite nuclear localization signalVirology1993 195596607

    Not in our library10.1006/viro.1993.1411

  124. 124.

    Ahmed M McKenzie MO Puckett S Hojnacki M Poliquin L Lyles DS Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesisJ Virol2003 7746464657

    Not in our library10.1128/jvi.77.8.4646-4657.2003

  125. 125.

    Ghildyal R Ho A Jans DA Central role of the respiratory syncytial virus matrix protein in infectionFEMS Microbiol Rev2006 30692705

    Not in our library10.1111/j.1574-6976.2006.00025.x

  126. 126.

    Takeda M Ohno S Seki F Nakatsu Y Tahara M Yanagi Y Long untranslated regions of the measles virus M and F genes control virus replication and cytopathogenicityJ Virol2005 791434614354

    Not in our library10.1128/jvi.79.22.14346-14354.2005

Cited by papers we hold 4

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.